Do surgical oncologists achieve lower rates of local‐regional recurrence in node positive breast cancer treated with mastectomy alone?

Adjuvant radiotherapy for node positive breast cancer postmastectomy has been recommended by two previously published randomized controlled trials (RCT). The local‐regional recurrence rates in the control arms, however, were considered by some critics to be excessive (> 25% at 10 years). Inadequate surgery, as evidenced by the low number of axillary nodes reported, may have resulted in the high local‐regional recurrence rates, allowing for the benefits seen with radiotherapy. Fellowship trained surgical oncologists might provide “better quality” surgery, resulting in lower recurrence rates and thus making adjuvant radiotherapy unnecessary. Our objective was to establish the local‐regional control rate postmastectomy in node positive breast cancer patients operated on by surgical oncologists, and to determine if treatment recommendations from previous RCTs are generalizable.

[1]  B. Hillner,et al.  Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Vermorken Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000, The Lancet.

[3]  J. Overgaard,et al.  Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment Alone , 2000 .

[4]  R. Gray,et al.  Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C L Soskolne,et al.  Surgeon-related factors and outcome in rectal cancer. , 1998, Annals of surgery.

[6]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[7]  N. Le,et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. , 1997, The New England journal of medicine.

[8]  R. Rubens,et al.  Loco-regional recurrence following mastectomy for early breast carcinoma: efficacy of radiotherapy at the time of recurrence. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  J. Willner,et al.  Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. , 1997, International journal of radiation oncology, biology, physics.

[10]  L. Marks,et al.  "One to three" or "four or more"? , 1997, Cancer.

[11]  B. Fowble,et al.  Postmastectomy radiation: then and now. , 1997, Oncology.

[12]  C. Gillis,et al.  Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland , 1996, BMJ.

[13]  P Hermanek,et al.  Prognostic factors of rectum carcinoma--experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. , 1995, Tumori.

[14]  G. Bonadonna,et al.  Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. , 1995, The New England journal of medicine.

[15]  E. Saettler,et al.  The surgeon as a prognostic factor in the management of pancreatic cancer. , 2000, Surgical oncology clinics of North America.

[16]  Mike Clarke,et al.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000 .